Oxcarbazepine-fgure5 (Oxcarbazepine Fgure 5)
Oxcarbazepine Suspension
Product Images NDC 31722-687
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 31722-687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Oxcarbazepine-fgure1 (Oxcarbazepine Fgure1)
A Kaplan-Meier survival curve graph illustrating the exit rate over time on trial from Day 2 to Day 11. The graph compares two treatment groups: Oxcarbazepine and Placebo, with the Placebo group showing a higher exit rate. The plot includes a log-rank test p-value of 0.0001, indicating statistical comparison of survival distributions between groups.*
Oxcarbazepine-fgure10 (Oxcarbazepine Fgure10)
An instructional illustration showing a person holding a bottle of OXCARBAZEPINE oral suspension and pressing the bottle's dropper or cap area with both hands. The bottle cap is shown removed and placed next to the bottle.*
Oxcarbazepine-fgure11 (Oxcarbazepine Fgure11)
An instructional illustration showing a hand holding a bottle and shaking it. The image emphasizes the proper technique for mixing an oral suspension before use.*
Oxcarbazepine-fgure12 (Oxcarbazepine Fgure12)
An instructional illustration showing how to use a dosing syringe to draw liquid medication from a suspension bottle. The syringe is positioned vertically above the bottle, with an arrow indicating downward movement to insert the syringe tip into the bottle's opening for accurate oral dosing.*
Oxcarbazepine-fgure13 (Oxcarbazepine Fgure13)
An instructional illustration showing how to measure liquid medication from a bottle using an oral syringe. The image depicts hands positioning the syringe vertically below the bottle, indicating to pull the syringe plunger downward to draw medication into the syringe for accurate dosing.*
Oxcarbazepine-fgure14 (Oxcarbazepine Fgure14)
An instructional diagram showing a person administering oral suspension medication using an oral syringe. The hand is pulling the plunger down to draw the dose, with a close-up magnified view highlighting measurement markings on the syringe indicating the liquid volume to be administered.*
Oxcarbazepine-fgure15 (Oxcarbazepine Fgure15)
An instructional illustration showing how to use a dosing syringe to draw medication from a bottle. The image depicts one hand holding a bottle of oral suspension while the other hand pulls back the syringe plunger to withdraw the dose.*
Oxcarbazepine-fgure16 (Oxcarbazepine Fgure16)
An instructional illustration showing a person using an oral syringe to administer liquid medication by mouth and another image of a hand withdrawing medication from a cup with an oral syringe. This diagram demonstrates how to properly measure and give oral suspension medication.*
Oxcarbazepine-fgure17 (Oxcarbazepine Fgure17)
Carton label for Oxcarbazepine Oral Suspension, USP 300 mg/5 mL, 250 mL bottle, by Camber Pharmaceuticals, Inc. The label includes dosage strength, instructions to shake well before use, storage conditions, dispensing information, and a U.S. contact number. It also notes the requirement to use within 7 weeks of opening and that the product is prescription only.*
Oxcarbazepine-fgure18 (Oxcarbazepine Fgure18)
Label for Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL bottle, manufactured by Camber Pharmaceuticals, Inc. The label includes dosage strength, instructions to shake well before use, storage conditions, packaging warnings, and includes a barcode. Manufactured by Hetero Labs Limited, India.*
Oxcarbazepine-fgure2 (Oxcarbazepine Fgure2)
A survival curve chart comparing time from first dose to first seizure between two treatment groups: Oxcarbazepine and placebo. The x-axis represents days from first dose to first seizure, while the y-axis shows the seizure rate. The chart includes a log-rank test p-value of 0.046, indicating statistical analysis of seizure occurrence over time.*
Oxcarbazepine-fgure3 (Oxcarbazepine Fgure3)
A survival analysis Kaplan-Meier plot depicting exit rates over time (days) for two treatment groups labeled as HIGH and LOW. The y-axis shows the exit rate from 0 to 1, and the x-axis represents time to exit in days up to 130. The plot includes a log-rank test with a p-value of 0.0001.*
Oxcarbazepine-fgure4 (Oxcarbazepine Fgure4)
A line graph showing exit rate over time (days) comparing two treatment groups labeled as HIGH and LOW. The graph includes a log-rank test p-value of 0.0001, indicating statistical analysis results. The x-axis represents time to exit in days, and the y-axis represents the exit rate.*
Oxcarbazepine-fgure6 (Oxcarbazepine Fgure6)
Oxcarbazepine 60 mg/mL oral suspension in a plastic container with a sealed, round cap. The container is translucent and cylindrical with a wide opening, designed for oral liquid medication. Labeler is Camber Pharmaceuticals, Inc.*
Oxcarbazepine-fgure7 (Oxcarbazepine Fgure7)
Bottle of OXCARBAZEPINE oral suspension, 60 mg/mL strength. The container is a clear bottle with a white child-resistant cap. The product is labeled as a human prescription drug by Camber Pharmaceuticals, Inc.*
Oxcarbazepine-fgure8 (Oxcarbazepine Fgure8)
An illustration diagram of a syringe showing its main parts labeled as Barrel and Plunger. The syringe appears to be used for measuring and dispensing liquid medications, relevant to oral suspension dosing.*
Oxcarbazepine-fgure9 (Oxcarbazepine Fgure9)
An illustration showing a hand holding and shaking a medicine bottle, demonstrating the action to shake the bottle before use.*
Oxcarbazepine-structure (Oxcarbazepine Structure)
Chemical structure of Oxcarbazepine illustrating the molecular framework including a dibenzazepine core with a ketone and amide functional groups.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
